More than 75,000 Kaiser Permanente workers threaten strike if labor agreement not reached

More than 75,000 Kaiser Permanente workers threaten strike if labor agreement not reached


Thousands of healthcare workers march down Vermont to call for the urgent need for improved working conditions, better support systems and increased investment in the healthcare workforce at Kaiser Permanente Los Angeles Medical Center in Hollywood on Monday, Sept. 4, 2023 in Los Angeles, CA.

Dania Maxwell | Los Angeles Times | Getty Images

More than 75,000 workers at the largest nonprofit health-care provider in the United States threatened Friday to strike if an agreement is not reached to resolve a staffing crisis by the end of next week.

A union coalition warned Kaiser Permanente that its members will walk out for three days in October at hundreds of health facilities across California, Colorado, Oregon, Washington, Virginia and Washington D.C., if a deal is not reached to relieve the issue.

The Coalition of Kaiser Permanente Unions issued the ultimatum after their final bargaining session concluded without an apparent resolution.

The unions said they will go on strike from Oct. 4 to 6 if an agreement is not reached when their current contract expires Sept. 30.

Kaiser Permanente serves nearly 13 million patients. It operates 39 hospitals and more than 600 medical offices across eight states and the District of Columbia.

CNBC Health & Science

Read CNBC’s latest health coverage:

Dave Regan, president of SEIU-United Healthcare Workers West, said that Kaiser has failed to adequately address a staffing crisis that has led to dangerous wait times for patients.

“Kaiser executives refuse to acknowledge how much patient care has deteriorated or how much the frontline healthcare workforce and patients are suffering because of the Kaiser short-staffing crisis,” Regan said in a statement

The Coalition of Kaiser Permanente Unions’ membership includes medical assistants, surgical and lab technicians, pharmacists and administrative staff among other health-care workers. Several unions voted overwhelmingly to authorize strikes at Kaiser last week.

Kaiser has called the unions’ claims misleading and urged employees to resist a call for a strike.

“The Coalition unions are positioned to strike in October. However, for the last 26 years of our historic labor-management partnership, we have reached agreements with the Coalition every time, with no strikes. A strike notice does not mean a strike will happen,” Kaiser said in a statement.

“Our top priority is caring for our members and patients, and we have plans in place to ensure we can continue to provide, high-quality care should a strike actually occur,” Kaiser said. “To be clear, we will continue to bargain in good faith until we reach a fair and equitable agreement that strengthens our position as a best place to work and ensures that the high-quality care our members expect from us remains affordable and easy to access.”



Source

2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market
Health

2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market

The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its next chapter. Patients are already getting their hands on the first GLP-1 pill for obesity from Danish drugmaker Novo Nordisk — a once-daily drug that shares the same brand name as its popular injection Wegovy. […]

Read More
Healthy Returns: What to expect from pharma at the JPM conference
Health

Healthy Returns: What to expect from pharma at the JPM conference

Heidi Overton, Novo Nordisk CEO Maziar Mike Doustdar, Eli Lilly CEO David A. Ricks, and U.S. Secretary of Commerce Howard Lutnick listen while U.S. President Donald Trump announces a deal with Eli Lilly and Novo Nordisk on to reduce the prices of GLP-1 weight‑loss drugs during an event in the Oval Office at the White […]

Read More
A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year
Health

A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year

Europe’s best-performing blue-chip stock in 2025 is widely expected to be bought by a larger peer, in a deal analysts say could be worth as much as $23 billion. Abivax, the French clinical-stage biotech company developing a treatment for ulcerative colitis and Crohn’s disease, saw shares rocket 1,681% last year, far outpacing the Stoxx 600 […]

Read More